- Home
- LSBK vs ANTX Comparison
LSBK vs ANTX Comparison
Compare LSBK & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LSBK | ANTX |
|---|---|---|
| Founded | 1891 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 109.6M |
| IPO Year | 2025 | 2022 |
Fundamental Metrics
Financial Performance| Metric | LSBK | ANTX |
|---|---|---|
| Price | $15.69 | $3.15 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 8.6K | ★ 387.5K |
| Earning Date | 04-24-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | ★ 49.23 | 32.56 |
| EPS | ★ 0.97 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $16.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.50 | $1.00 |
| 52 Week High | $16.22 | $6.91 |
Technical Indicators
Market Signals| Indicator | LSBK | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.50 | 47.90 |
| Support Level | $15.26 | $1.06 |
| Resistance Level | $15.68 | $6.91 |
| Average True Range (ATR) | 0.17 | 0.32 |
| MACD | 0.04 | -0.11 |
| Stochastic Oscillator | 71.43 | 23.11 |
Price Performance
Historical ComparisonAbout LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holding company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit, and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.